Scopus BioPharma Inc. (OTCPK: SCPS)
Health Care · Biotechnology · US
$0.00
-33.33% today · +33.3% 1Y
Scopus BioPharma Inc. (OTCPK: SCPS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.83K and employs 13 people.
Over the last twelve months the share price has gained 33.3%, trading between 0.00 and 0.01.
Tweenvest scores Scopus BioPharma Inc. across four factors: quality 20/100, value 35/100. Its strongest factor is value.
SCPS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.83K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.31
- Dividend yield
- —
- Beta (5Y)
- 30.04
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 42.08M
- Employees
- 13
- Next earnings
- —
About Scopus BioPharma Inc.
Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer. The company's offerings include the Duet Platform, which incorporates CpG signal transducer and activator of transcription 3 (STAT3) inhibitors. Another significant product is MRI-1867, a cleverly engineered, orally administered, dual-action hybrid small molecule. MRI-1867 functions as an inverse agonist of the endocannabinoid system's cannabinoid receptor 1 (CB1) and additionally acts as an inhibitor of inducible nitric oxide synthase (iNOS). To advance its key development efforts and other programs, Scopus BioPharma has established strategic collaborations with prominent organizations such as the City of Hope, the National Institutes of Health Program, and The Hebrew University of Jerusalem. Established in 2017, the company was originally named Project18 Inc. before officially rebranding to Scopus BioPharma Inc. in December of that year. Its corporate headquarters are located in New York, New York.
- ISIN
- US8091711015
- Founded
- 2017
- Listed since
- Dec 16, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Carisma Therapeutics, Inc.OTCPK: CARM | $20.92K | $0.00 | -37.50% |
| Dragon Life Science Holdings Group, Inc.OTCPK: NOHO | $20.04K | $0.00 | — |
| T2 Biosystems, Inc.OTCPK: TTOO | $19.63K | $0.00 | +16.67% |
| Neovacs S.A.ENXTPA: ALNEV | $17.12K | €0.10 | -3.90% |
| Bio-Path Holdings, Inc.OTCPK: BPTH | $16.17K | $0.00 | +50.00% |
| CardioGenics Holdings IncOTCPK: CGNH | $14.29K | $0.00 | — |
| Vaxxinity, Inc.OTCPK: VAXX | $12.68K | $0.00 | -99.60% |
| ObsEva SAOTCPK: OBSE.F | $11.72K | $0.00 | +9900.00% |
Figures last refreshed Oct 18, 2026.